Malta - English - Medicines Authority

sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - meropenem - powder for solution for infusion or injection - meropenem 500 mg - antibacterials for systemic use

Malta - English - Medicines Authority

sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - meropenem - powder for solution for infusion or injection - meropenem 1000 mg - antibacterials for systemic use

Malta - English - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - meropenem - powder for solution for infusion or injection - meropenem 500 mg - antibacterials for systemic use

Malta - English - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - meropenem - powder for solution for infusion or injection - meropenem 1 g - antibacterials for systemic use

Malta - English - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - meropenem - powder for solution for infusion or injection - meropenem 500 mg - antibacterials for systemic use

Malta - English - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - meropenem - powder for solution for infusion or injection - meropenem 1 g - antibacterials for systemic use

Malta - English - Medicines Authority

hospira uk limited - meropenem - powder for solution for infusion or injection - meropenem 500 mg - antibacterials for systemic use

Malta - English - Medicines Authority

hospira uk limited - meropenem - powder for solution for infusion or injection - meropenem 1 g - antibacterials for systemic use

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - meropenem trihydrate 1140mg equivalent to meropenem 1000mg;   - powder for injection - 1000 mg - active: meropenem trihydrate 1140mg equivalent to meropenem 1000mg   excipient: sodium carbonate - meropenem-aft is indicated for treatment, in adults and children, of the following infections caused by multiple susceptible bacteria and as empiric therapy prior to the identification of the causative organisms: · lower respiratory tract infections · urinary tract infections, including complicated infections · intra-abdominal infections · gynaecological infections, including postpartum infections · skin and skin structure infections · meningitis · septicaemia · empiric treatment, including initial monotherapy, for presumed bacterial infections in host-compromised, neutropenic patients because of its broad spectrum of bactericidal activity against gram positive and gram-negative aerobic and anaerobic bacteria, meropenem is effective for the treatment of polymicrobial infections.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - meropenem trihydrate 570mg equivalent to meropenem 500mg;   - powder for injection - 500 mg - active: meropenem trihydrate 570mg equivalent to meropenem 500mg   excipient: sodium carbonate - meropenem-aft is indicated for treatment, in adults and children, of the following infections caused by multiple susceptible bacteria and as empiric therapy prior to the identification of the causative organisms: · lower respiratory tract infections · urinary tract infections, including complicated infections · intra-abdominal infections · gynaecological infections, including postpartum infections · skin and skin structure infections · meningitis · septicaemia · empiric treatment, including initial monotherapy, for presumed bacterial infections in host-compromised, neutropenic patients because of its broad spectrum of bactericidal activity against gram positive and gram-negative aerobic and anaerobic bacteria, meropenem is effective for the treatment of polymicrobial infections.